B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by FGFR in disease

REACTOME PATHWAY
Reactome: R-HSA-122609911 genes29 compounds

The Signaling by FGFR in disease pathway (Reactome ID: R-HSA-1226099) involves 11 genes and is affected by 29 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

BCRFGF22FGFR1FGFR2FGFR3FGFR4GRB2PIK3R1STAT1STAT3STAT5A

Compounds Affecting Signaling by FGFR in disease

#CompoundTargets HitStudies
1Sorafenib300
2Axitinib298
3Dasatinib299
4Crizotinib298
5sp600125117
619-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]300
7triolimus [Supplementary Concept]33
8pterostilbene299
9Imatinib Mesylate300
10pictilisib25
11Wortmannin300
12ly29400211
13alpelisib227
14Sirolimus300
15torin 110
16Quercetin300
17Budesonide1,000
18Methylene Blue200
19egcg300
20Flurandrenolone65
21Hexachlorophene300
22streptonigrin299
23alsterpaullone12
24Niclosamide299
25Fingolimod Hydrochloride56
26Celecoxib295
27myricetin-3-O-galactopyranoside [Supplementary Concept]300
28Acrylamide300
29Dactinomycin297

About the Signaling by FGFR in disease Pathway

The Signaling by FGFR in disease pathway is catalogued in Reactome (ID: R-HSA-1226099) and involves 11 genes. In the BiohacksAI corpus, 29 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BCR, FGF22, FGFR1, FGFR2, FGFR3.